<DOC>
	<DOC>NCT00620230</DOC>
	<brief_summary>This study will evaluate the safety and tolerability of single and multiple doses of VAK694 in healthy volunteers and otherwise healthy volunteers with a history of allergies.</brief_summary>
	<brief_title>Safety and Tolerability of Single and Multiple Doses of VAK694 in Healthy and Atopic Subjects</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>History of allergic rhinitis (Part 2 only) Very low or high body weight Heavy or recent smoker Exposure to human monoclonal antibodies Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Allergic rhinitis, anti-interleukin 4</keyword>
</DOC>